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Tuesday, August 31, 2021 
 
 
During this COVID-19 pandemic and other future events, the CDM has been 
and will continue to be a source of reliable information, education and models 
for mitigation, preparedness, response, and recovery.  We hope this 
informational document has helped provide you filtered and actionable 
information.  As the pace of new information and changes occur, we will 
evaluate the current once per week to determine if this information should be 
provided on a more frequent basis.   
 
 
                                                                                                                        
David Markenson, M.D., M.B.A. 
Director 









 Total Cases Total Deaths Total Vaccine 
Doses Admin. 
Worldwide 217,088,286 4,509, 852 5,244,324,964 
United States 39,057,368 638,711 368,419,046 
New Jersey 1,088,330 26,849 11,084,973 
New York 2,269,038 54,199 24,328,502 
Connecticut 370,708 8,358 4,817,190 
 
Information as of 8/31/21 at 0100 EDT. Source: https://coronavirus.jhu.edu/map.html  
 





Center for Disaster Medicine Updates 
 
• Coordinating and overseeing COVID-19 screenings at NYMC campus. 
• Continue to partner with local organizations such as Westchester Department of Emergency 
Services and Westchester Medical Center to ensure ongoing collaboration with all public 
safety agencies. 
• Coordinating volunteers to support local public health response to COVID-19. 
• Conducting research and analysis of current events and COVID-19 response to identify 
strengths and areas for improvement in other regions. 
• Updating and developing new programs to provide enhanced education on public health 
emergencies including pandemics. 
• Exploring course development opportunities in infection prevention and control for frontline 
responders in the hospital and in the field. 
• Serving as a source of information for COVID-19 related concerns or questions regarding 
public health, emergency medical service (EMS), public safety and healthcare response. 
• Local networking and pandemic response analysis for New York’s tri-state area, using first-
person experiences to highlight current trends. 
 
To view the Center for Disaster Medicine's newest webinar, please click here - The 




• As of August 30, 2021, Whole of Government Focuses on Lifesaving Measures, Power 
Restoration for Hurricane Ida Response- A tremendous coordination effort is taking 
place at all levels of government and utilizing assets from across the nation to conduct 




The White  
 
On August 27, 2021, President Biden provided an update on the COVID- ⁠19 Response and the 
Vaccination Program- Jeff Zients, Dr. Walensky and Dr. Fauci provided an update regarding 




On August 27, 2021, President Biden provided a statement on the Investigation into the Origins 




The official website of the White House will deliver updated information as the country grapples 
with converging crises. This will include actions to control the COVID-19 pandemic, provide 
economic relief, tackle climate change, and advance racial equity and civil rights, as well as 
immediate actions to reform our immigration system and restore America’s standing in the world. 




Health and Human Services (HHS) 
 
Biden-Harris Administration Releases Medicaid and CHIP Guidance Targeting Vaccination and 
Testing for COVID-19- As part of its implementation of the American Rescue Plan Act of 2021 
(ARP), the Biden-Harris Administration issued guidance that provides essential information to 
states as they navigate the options available to advance COVID-19 vaccination and testing, and 





For the latest COVID-19 information from HHS 
https://www.hhs.gov/about/news/coronavirus/index.html 
 





United States Food and Drug Administration (FDA) 
 
As of August 27, 2021, 407 tests and sample collection devices are authorized by the 
FDA under emergency use authorizations (EUAs). These include 285 molecular tests and 
sample collection devices, 88 antibody and other immune response tests and 34 antigen 
tests. There are 60 molecular authorizations and one antibody authorization that can be 
used with home-collected samples. There is one molecular prescription at-home test, 
three antigen prescription at-home tests, seven antigen over-the-counter (OTC) at-home 
tests and two molecular OTC at-home tests. The FDA has authorized 14 antigen tests 
NIH launches study of extra COVID-19 vaccine dose in people with autoimmune disease- The 
National Institutes of Health has begun a clinical trial to assess the antibody response to an extra 
dose of an authorized or approved COVID-19 vaccine in people with autoimmune disease who 
did not respond to an original COVID-19 vaccine regimen. The trial also will investigate whether 
pausing immunosuppressive therapy for autoimmune disease improves the antibody response to 
an extra dose of a COVID-19 vaccine in this population. The Phase 2 trial is sponsored and 
funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, and is 








and eight molecular tests for serial screening programs. The FDA has also authorized 613 








Centers for Disease Control and Prevention (CDC) 
On August 30, 2021, the CDC provided a statement following ACIP Pfizer-BioNTech 
Vote- CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory 
Committee on Immunization Practices’ (ACIP) recommendation for use of the Pfizer-
BioNTech’s licensed vaccine for people 16 and older. 
https://www.cdc.gov/media/releases/2021/s0830-pfizer-vote.html  
 
On August 27, 2021, the CDC provided updated guidance regarding COVID-19 Vaccines 
for Moderately to Severely Immunocompromised People- CDC continues to recommend 
the use of the newly FDA-approved Pfizer-BioNTech (COMIRNATY) COVID-19 Vaccine 
for people 16 years and older, as one of the recommended vaccines to protect against 
COVID-19. CDC continues to recommend the vaccine under an emergency use 
authorization (EUA) for adolescents 12 through 15 years old, as well as an additional 
mRNA dose for moderately to severely immunocompromised people. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html  
 
On August 25, 2021, the CDC provided updated guidance regarding school testing and 
COVID-19- Given new evidence on the B.1.617.2 (Delta) variant, CDC has updated the 
guidance for fully vaccinated people. CDC recommends universal indoor masking for all 
teachers, staff, students, and visitors to K-12 schools, regardless of vaccination status. 
Children should return to full-time in-person learning in the fall with layered prevention 




CDC provides updated information about the variants in the United States- The emerging 
variants CDC is closely monitoring have mutations in the virus genome that alter the 
characteristics and cause the virus to act differently in ways that are significant to public 
health (e.g., causes more severe disease, spreads more easily between humans, 
requires different treatments, changes the effectiveness of current vaccines). It’s 
important to understand that genetic mutations are expected, and some variants can 
spread and become predominant while others subside. 
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html  
 
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and 
trends of COVID-19 in the United States- updated daily by 8 p.m. ET. 
https://covid.cdc.gov/covid-data-tracker/#datatracker-home  
 
For the latest CDC information 
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html 
 
Center for Medicare and Medicaid Services (CMS)   
Biden-Harris Administration Releases Medicaid and CHIP Guidance Targeting 
Vaccination and Testing for COVID-19- To help states support families and communities 
and to continue to address health disparities, the Centers for Medicare & Medicaid 
Services (CMS) will provide guidance to states about additional ARP funding for states to 





Affordable Care Act’s Shared Savings Program Continues to Improve Quality of Care 
While Saving Medicare Money During the COVID-19 Pandemic- The Centers for 
Medicare & Medicaid Services (CMS) announced today that Accountable Care 
Organizations (ACOs) participating in the Medicare Shared Savings Program (Shared 
Savings Program) in 2020 earned performance payments (shared savings) totaling nearly 
$2.3 billion while saving Medicare approximately $1.9 billion, marking the fourth 











In this section, vaccine-related information from various sources will be collected, 
reviewed, and tabulated here.  As of August 31, 2021, the FDA has granted Emergency 
Use Authorization (EUA) to Moderna and Janssen/Johnson & Johnson. On August 23, 
2021, the FDA granted full approval to Pfizer. Now with two vaccines with EUA and one 
vaccine with full FDA approval, the goal is to vaccinate a larger number of persons in the 
coming months throughout the United States. As additional vaccines are granted EUA, 
information for those vaccines will also be included. 
 
CDC created this section regarding COVID-19 vaccinations in the United States- CDC 
provides overall US COVID-19 Vaccine, deliveries and administration, maps, charts, and 
data updated daily by 8 PM. This section represents all vaccine partners including 
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal 
Emergency Management Agency and Health Resources and Services Administration 
partner sites, and federal entity facilities.  
https://covid.cdc.gov/covid-data-tracker/#vaccinations  
 
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the 
distribution of the vaccine including the number of doses received by the state, a 
breakdown of first or second doses, and the number of persons vaccinated with the first 
and second doses in each region. 
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker  
 
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide 
updated relevant information including side effects and safety data, clinical trials 
demographic statistics, and information on how the vaccine works. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html  
 
CDC created this section regarding the Moderna vaccine to provide updated relevant 
information including side effects and safety data, clinical trials demographic statistics, 
and information on how the vaccine works. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html   
 
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated 
relevant information including side effects and safety data, clinical trials demographic 




HHS created this section to provide the latest information about COVID-19 vaccines. 
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html  
 
For NYC DOHMH updated guidance regarding COVID-19 vaccine 
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page  
 
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19 
vaccination location. The Vaccine Finder can also provide New Yorkers with information 
to schedule vaccination appointments. 
https://vaccinefinder.nyc.gov/ 
 
Educational Institution Information 
• Higher Education 
o A professor at the University of Georgia, who has previously retired but 
was hired back to teach an upper-level psychology course, quit the 




o In Hoboken, New Jersey, the district's reopening plan requires students 
over age 12 to be vaccinated or face weekly testing. Many districts began 
mandating vaccination for school staff prior to the U.S. Food and Drug 
Administration's approval of the Pfizer-BioNTech vaccine for COVID-19, 
which was previously authorized for emergency use, and growing 
momentum for student mandates comes alongside a boost to those 





To view the latest information on clinical trials regarding COVID-19 
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=  











• On August 25, 2021, Governor Kathy Hochul announced changes to New York State's 
$800 million COVID-19 Pandemic Small Business Recovery Grant Program that will 
enable more small businesses to apply for funding. Businesses with revenues up to $2.5 
million can apply for grants, up from the previous threshold of $500,000. Additionally, the 
limitation for businesses that received Federal Paycheck Protection Program loans has 




New York State Department of Health (DOH) 
 
On August 30, 2021, Governor Hochul updated New Yorkers on the state's progress combating 
COVID-19. "While we have come so far in containing COVID, the virus is still a threat to our 
communities - it is up to us to prevent it from spreading any further," Governor Hochul said. 
"Wear a mask, wash your hands and, if you haven't already, get vaccinated today. The vaccine 









NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information 
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down 











• As the State of Connecticut continues taking actions in response to the global spread of 
coronavirus disease (COVID-19), Governor Ned Lamont provided an update as of 3:00 
p.m. on Monday, August 30, 2021.  
https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2021/08-
2021/Governor-Lamont-Coronavirus-Update-August-30  
• On August 27, 2021, Governor Ned Lamont announced that the U.S. Department of 
Education has approved his administration’s plan for use of the $110 million the State of 
Connecticut is receiving from the federal American Rescue Plan Act of 2021, 
Elementary and Secondary School Emergency Relief Fund. The funding was approved 
by Congress and signed into law by President Joe Biden earlier this year as part of the 









Local Updates  
 
New York Blood Center (NYBC) 
 
For the latest updated NYBC information about COVID-19: 
https://nybc.org/covid-19/  
 
New York City (NYC) Department of Health and Mental Hygiene (DOHMH)   
 
NYC DOHMH launched a new variants data page. The data on this page show how variants of the 
virus that causes COVID-19 are spreading in NYC. Variants are versions of the virus with certain 
sets of mutations. Some variants may result in a COVID-19 infection that is easier to spread, more 
severe or able to avoid antibodies from vaccines or previous infections. 
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page  
 
For NYC DOHMH updated COVID-19 data page 
https://www1.nyc.gov/site/doh/covid/covid-19-data.page  
 
For the latest COVID-19 information from NYC DOHMH 
https://www1.nyc.gov/site/doh/covid/covid-19-main.page  
 
Westchester County Department of Health 
 
For the latest breakdown of positive cases in Westchester County as of August 29, 2021 
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d  
 
For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams 
offering earlier access to vaccines. 
https://health.westchestergov.com/2019-novel-coronavirus   
 
Putnam County Department of Health 
Breakdown of positive cases by towns in Putnam County as of August 27 , 2021- 
https://www.putnamcountyny.com/covid19/  
 
For the latest COVID-19 information 
https://www.putnamcountyny.com/health/coronavirus/ 
 
Dutchess County Department of Health 
 
Breakdown of positive cases in Dutchess County as of August 30, 2021 
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm 
 
For the latest COVID-19 information: 
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm 
 
Orange County Department of Health   
 
Updated COVID-19 dashboard for Orange County, NY as of August 30, 2021 
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71 
 




Rockland County Department of Health 
 
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of 
August 30, 2021 
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096  
 






For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital 




Center for Disaster Medicine Media 
 
WMCHealth Post-COVID-19 Recovery Program began in June 2020 




Gary Rogg, M.D., assistant professor of medicine 
 




Gary Rogg, M.D., assistant professor of medicine 
 
Masking and Vaccinations are the Key Ingredients to Attain COVID-19 Herd Immunity 




John Loike, Ph.D., interim director of the Master of Science Degree and the Graduate 
Certificate program in Medical Ethics and Humanities, SHSP 
 
Every effort is made to provide accurate and complete information in this newsletter. However, New 
York Medical College cannot guarantee that there will be no errors. NYMC makes no claims, promises or 
guarantees about the accuracy, completeness, or adequacy of the contents of the newsletters or the 
articles linked herein and further expressly disclaims liability for errors and omissions in the contents of 
this newsletter.  
 
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the 







New York Medical College 
Center for Disaster Medicine 
7 Dana Road Suite 511 
Valhalla, New York 10595 
914-594-1750 
https://www.nymc.edu/center-for-disaster-medicine/ 
 
 
 
 
 
 
